title: Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production.
abstract: OBJECTIVE
  The factors that lead to myointimal hyperplasia (MH) in arterial vein grafts (AVGs) are unknown. Platelet-derived growth factor (PDGF) and basic fibroblastic growth factor (bFGF) are two powerful mitogens for smooth muscle cells that have been implicated in the genesis of MH. The aim of this study was to analyze the correlation between progression and regression of MH and production of PDGF and bFGF in experimental vein grafts.
  
  
  METHODS
  In 64 inbred Lewis rats, a 1-cm segment of inferior vena cava was inserted at the level of the abdominal aorta. The segments of inferior vena cava were obtained from syngenic rats. In 48 rats, the AVG was explanted 3 days (n = 8), 7 days (n = 8), 4 weeks (n = 24), and 12 weeks (n = 8) after surgery. In 16 rats the vein graft was explanted after being in the arterial system for 4 weeks and was reimplanted as a venous-venous bypass in syngenic Lewis rats. Reimplanted vein grafts (RVGs) were explanted 2 weeks (n = 8) and 8 weeks (n = 8) later. Grafts were analyzed by light and electron microscopy, morphometry, and histochemistry, and were put in organ culture to assess PDGF and bFGF production and mitogenic activity.
  
  
  RESULTS
  We observed MH formation in AVGs and MH regression in RVGs (p < 0.001).PDGF and bFGF production correlated with the degree of MH (p < 0.01). Histochemistry showed PDGF and bFGF in the area of MH in AVG, which disappeared in RVG. Conditioned media from AVG had greater mitogenic activity than RVG or control veins.
  
  
  CONCLUSIONS
  MH formation and regression in experimental vein grafts correlate with PDGF and bFGF production.
authors.affiliation: First Department of Surgery, University of Rome, La Sapienza, Italy.
authors.forename: A V
authors.initials: AV
authors.lastname: Sterpetti
authors.forename: A
authors.initials: A
authors.lastname: Cucina
authors.forename: S
authors.initials: S
authors.lastname: Lepidi
authors.forename: B
authors.initials: B
authors.lastname: Randone
authors.forename: F
authors.initials: F
authors.lastname: Stipa
authors.forename: C
authors.initials: C
authors.lastname: Aromatario
authors.forename: D
authors.initials: D
authors.lastname: Travi
authors.forename: L S
authors.initials: LS
authors.lastname: D'Angelo
authors.forename: A
authors.initials: A
authors.lastname: Cavallaro
authors.forename: S
authors.initials: S
authors.lastname: Stipa
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001012:Aorta, Abdominal / Q000601:surgery; D017077:Culture Media, Conditioned; D018450:Disease Progression; D016222:Fibroblast Growth Factor 2 / Q000032:analysis / Q000378:metabolism*; D006651:Histocytochemistry; D006965:Hyperplasia; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D008934:Mitogens / Q000032:analysis / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology*; D009924:Organ Culture Techniques; D010982:Platelet-Derived Growth Factor / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D011917:Rats, Inbred Lew; D012075:Remission, Spontaneous; D012092:Replantation; D017539:Tunica Intima / Q000187:drug effects / Q000473:pathology*; D014680:Veins / Q000601:surgery; D014682:Vena Cava, Inferior / Q000378:metabolism / Q000473:pathology / Q000637:transplantation*
chemical_list: D017077:Culture Media, Conditioned; D008934:Mitogens; D010982:Platelet-Derived Growth Factor; D016222:Fibroblast Growth Factor 2